Argent Capital Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

Argent Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$19.12 - $22.62 $3.6 Million - $4.26 Million	-188,140 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$18.92 - $22.96 $405,077 - $491,573	-21,410 Reduced 10.22%	188,140 $3.97 Million
Q1 2019 May 10, 2019	SELL	$19.46 - $25.28 $502,068 - $652,224	-25,800 Reduced 10.96%	209,550 $4.28 Million
Q4 2018 Feb 12, 2019	SELL	$17.72 - $22.51 $7,530 - $9,566	-425 Reduced 0.18%	235,350 $4.68 Million
Q2 2018 Aug 09, 2018	BUY	$14.63 - $19.6 $73,150 - $98,000	5,000 Added 2.17%	235,775 $3.6 Million
Q1 2018 May 03, 2018	BUY	$17.23 - $20.35 $17,833 - $21,062	1,035 Added 0.45%	230,775 $4.33 Million
Q4 2017 Feb 14, 2018	BUY	$17.76 - $19.75 $1.93 Million - $2.14 Million	108,465 Added 89.44%	229,740 $4.28 Million
Q3 2017 Nov 15, 2017	BUY	$14.73 - $17.99 $904,790 - $1.11 Million	61,425 Added 102.63%	121,275 $2.17 Million
Q2 2017 Aug 15, 2017	BUY	N/A	59,850	59,850 $1.07 Million

281

36.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.59B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Argent Capital Management LLC with notifications on news.